Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
Open Access
- 21 February 2017
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 31 (6) , 2393-2404
Abstract
Cell surface glycosylation is thought to be involved in barrier function against microbes at mucosal surfaces. Previously we showed that the epithelium of healthy mouse corneas becomes vulnerable to Pseudomonas aeruginosa adhesion if it lacks the innate defense protein MyD88 (myeloid differentiation primary response gene 88), or after superficial injury by blotting with tissue paper. Here we explored their effect on corneal surface glycosylation using a metabolic label, tetra‐acetylated N ‐azidoacetylgalactosamine (Ac 4 GalNAz). Ac 4 GalNAz treatment labeled the surface of healthy mouse corneas, leaving most cells viable, and bacteria preferentially associated with GalNAz‐labeled regions. Surprisingly, corneas from MyD88‐/‐ mice displayed similar GalNAz labeling to wild‐type corneas, but labeling was reduced and patchy on IL‐1 receptor (IL‐1R)‐knockout mouse corneas ( P < 0.05, ANOVA). Tissue paper blotting removed GalNAz‐labeled surface cells, causing DAPI labeling (permeabilization) of underlying cells. MS of material collected on the tissue paper blots revealed 67 GalNAz‐labeled proteins, including intracellular proteins. These data show that the normal distribution of surface glycosylation requires IL‐1R, but not MyD88, and is not sufficient to prevent bacterial binding. They also suggest increased P. aeruginosa adhesion to MyD88‐/‐ and blotted corneas is not due to reduction in total surface glycosylation, and for tissue paper blotting is likely due to cell permeabilization.—Jolly, A. L., Agarwal, P., Metruccio, M. M. E., Spiciarich, D. R., Evans, D. J., Bertozzi, C. R., Fleiszig, S. M. J. Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding. FASEB J. 31, 2393–2404 (2017). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health (EY011221, EY024060)
- National Cancer Institute (CA200423)
- National Institute of General Medical Sciences (GM058867)
- National Science Foundation
This publication has 55 references indexed in Scilit:
- Design of a superior cytokine antagonist for topical ophthalmic useProceedings of the National Academy of Sciences, 2013
- Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptidesMucosal Immunology, 2012
- Modulation of epithelial immunity by mucosal fluidScientific Reports, 2011
- Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cellsExperimental Eye Research, 2011
- Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathwayProceedings of the National Academy of Sciences, 2011
- Broad-Host-Range Plasmids for Red Fluorescent Protein Labeling of Gram-Negative Bacteria for Use in the Zebrafish Model SystemApplied and Environmental Microbiology, 2010
- Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF‐βJournal of Cellular Physiology, 2010
- Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial BarrierJournal of Biological Chemistry, 2009
- Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1Journal of Biological Chemistry, 2008
- In Vivo Imaging of Membrane-Associated Glycans in Developing ZebrafishScience, 2008